Latest Innovation News

TechnologyOne has delivered a standout FY25 performance, beating profit guidance and accelerating its ARR growth well ahead of schedule, powered by its innovative SaaS+ model and strong UK market traction.

Cobalt Blue Holdings is pivoting its Broken Hill Technology Centre to process battery black mass, aiming to secure a sustainable domestic feedstock for its Kwinana Cobalt Refinery and unlock near-term revenue opportunities.

Etherstack plc has successfully raised $6.1 million through an institutional placement, positioning the company to fast-track its Home project and enhance its MCPTX IWF technology.

Kincora Copper has begun its inaugural basement drilling at the Wongarbon porphyry project, targeting a major gold-copper system supported by NSW government funding and cutting-edge AI technology.

Green Technology Metals advances its Ontario lithium projects with a streamlined environmental footprint and strong government backing, positioning for a lithium market recovery in 2026.

Tryptamine Therapeutics has enrolled its second patient in a pioneering clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with first dosing scheduled for December and results expected early next year.

Meteoric Resources has successfully completed wet commissioning of its pilot plant in Brazil, marking a key milestone towards rare earth production at the Caldeira Project. First Mixed Rare Earth Carbonate output is expected early December, supporting ongoing feasibility studies and offtake partnerships.

Power Minerals has partnered with Australian tech firm Gega Elements to develop a gallium extraction process from its Santa Anna Project in Brazil, aiming to establish a vertically integrated supply chain amid rising global demand and supply risks.

Infomedia Ltd shareholders have overwhelmingly approved a scheme of arrangement for acquisition by TPG Capital, valuing the company at approximately AUD 651 million. The deal, supported by the board and an independent expert, is set to complete by early December 2025.

Radiopharm Theranostics has secured ethics approval to begin a Phase 1 clinical trial of RAD 402, a pioneering radiotherapeutic targeting advanced prostate cancer using terbium-161. This marks a significant step in developing a potentially safer, more effective treatment option.

Plenti Group Limited reported a robust half-year performance for 1H26, with a 24% increase in its loan portfolio and a 147% surge in Cash Profit Before Tax, underscoring its growing market presence and operational efficiency.

Plenti Group Limited has reported a remarkable half-year performance for FY26, with revenues up 20% and profit soaring over tenfold to $10.5 million. The fintech lender’s loan portfolio expanded 24%, driven by strong demand across automotive, renewable energy, and personal loans.